Evidence map›Paper›PMID 35110323›Full record

ArticleBMJ open2022

Demographic, clinical guideline criteria, Medicaid expansion and state of residency: a multilevel analysis of PrEP use on a large US sample.

Pedro Botti Carneiro, Chloe Mirzayi, Scott Jones, Jonathon Rendina, Christian Grov

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies.AIDS education and prevention : official publication of the International Society for AIDS Education · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Pedro Botti CarneiroCommunity Health and Health Policy, CUNY School of Public Health, New York, New York, USA pedro.carneiro74@sphmail.cuny.edu.ORCID 0000-0002-4638-7824
Chloe MirzayiCommunity Health and Health Policy, CUNY School of Public Health, New York, New York, USA.ORCID 0000-0002-9817-2868
Scott JonesWhitman-Walker Clinic, Washington, District of Columbia, USA.
Jonathon RendinaWhitman-Walker Clinic, Washington, District of Columbia, USA.
Christian GrovCommunity Health and Health Policy, CUNY School of Public Health, New York, New York, USA.
City University of New York · USCUNY School of Law · USMilken Institute · USThe Graduate Center, CUNY · USWhitman-Walker Health · US

Funding

Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and CareUH3AI133675 · NIAID · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI GROV, CHRISTIAN · 2019 to 2021
$6.9M
Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk MenUH3AI133674 · NIAID · WHITMAN-WALKER INSTITUTE, INC. · PI RENDINA, H. JONATHON · 2019 to 2021
$3.9M
Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk MenUG3AI133674 · NIAID · HUNTER COLLEGE · PI RENDINA, H. JONATHON · 2017 to 2019
$3.2M
NIAID NIH HHS UG3 AI133674NIAID NIH HHS UH3 AI133674NIAID NIH HHS UH3 AI133675
6 · The paper itself

Abstract

objectiveTo explore the association of clinical guideline-related variables, demographics and Medicaid expansion on pre-exposure prophylaxis (PrEP) uptake in one of the largest US sample of men who have sex with men(MSM) and transgender and gender non-binary (TGNB) people ever analysed.

methodsWe cross-sectionally analysed predictors of current PrEP use using demographic and HIV risk-related variables (level-1), as well as state-level variables (level-2) (ie, Medicaid expansion status). We further explored the role state of residence plays in PrEP uptake disparities across the USA.

resultsWe found that the odds of PrEP use were significantly greater in older age, white, cisgender men. Moreover, individuals who reported recent post-exposure prophylaxis use, a recent sexually transmitted infection diagnosis and recent drug use were significantly more likely to report PrEP use. Finally, we found that the median odds of PrEP use between similar individuals from different states were 1.40 for the ones living in the Medicaid expansion states, compared with those not living in Medicaid expansion states. State of residence did not play a significant role in explaining PrEP disparities overall.

conclusionOur analysis showed that PrEP use is less common in communities standing to benefit the most from it-young MSM and TGNB of colour. However, individuals meeting federal guidelines for PrEP were significantly more likely to use PrEP. Though we found a positive association between living in Medicaid expansion states and PrEP use; that variable, as well as one's state of residency, were not suitable to explain variations in PrEP use in the US.

Indexed as

Anti-HIV AgentsHIV InfectionsInternship and ResidencyPre-Exposure ProphylaxisSexual and Gender MinoritiesDemographyHomosexuality, MaleHumansMaleMedicaidMultilevel AnalysisUnited StatesAnti-HIV AgentsepidemiologyHIV & AIDSpreventive medicinepublic health

Identifiers

PMID35110323
PMCPMC8811583
OpenAlexW4210635298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.